317
Views
7
CrossRef citations to date
0
Altmetric
Articles

Effects of erythropoietin pretreatment on single dose pentylentetrazole-induced seizures in rats

, , &

References

  • Adamcio B, Sargin D, Stradomska A, Medrihan L, Gertler C, Theis F., Zhang M, Müller M, Hassouna I, Hannke K, Sperling S, Radyushkin K, El-Kordi A, Schulze L, Ronnenberg A, Wolf F, Brose N, Rhee JS, Weiqi Z. 2008. Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol. 6:37. doi:10.1186/1741-7007-6-37.
  • Ay H, Topal T, Uysal B, Özler M, Öter S, Korkmaz A, Dündar K. 2007. Time-dependent course of hyperbaric oxygen-induced oxidative effects in rat lung and erythrocytes. Clin Exp Pharmacol Physiol 34:787–791.
  • Bahçekapılı N, Akgün-Dar K, Albeniz I, Kapucu A, Kandil A, Yağız O, Üzüm G. 2014. Erythropoietin pretreatment suppresses seizures and prevents the increase in inflammatory mediators during pentylenetetrazole-induced generalized seizures. Int J Neurosci. 124:762–770.
  • Bartesaghi S, Marinovich M, Corsini E, Galli CL, Viviani B. 2005. Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology. 26:923–928.
  • Biagini G, D’Arcangelo G, Baldelli E, D’Antuono M, Tancredi V, Avoli M. 2005. Impaired activation of CA3 pyramidal neurons in the epileptic hippocampus. Neuromol Med. 7:325–342.
  • Binder DK, Croll SD, Gall CM, Scharfman HE. 2001. BDNF and epilepsy: too much of a good thing? Trends Neurosci. 24:47–53.
  • Bramham CR, Messaoudi E. 2005. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol. 76:99–125.
  • Brines ML, Ghezzi P, Keenan S, Agnello D, De Lanerolle NC, Cerami C, Itri LM, Cerami A. 2000. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA. 97:10526–10531.
  • Bumb JM, Aksay SS, Janke C, Kranaster L, Geisel O, Gass P, Hellweget R, Sartorius A. 2015. Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients. Eur Arch Psych Clin Neurosci. 265:227–232.
  • Corcoran R, Thompson P. 1992. Memory failure in epilepsy: retrospective reports and prospective recordings. Seizure 1:37–42.
  • Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA. 2009. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1–uncoupling protein 2 pathway. J Neurosci. 159:993–1002.
  • Deng Y, Wang M, Wang W, Ma C, He N. 2013. Comparison and effects of acute lamotrigine treatment on extracellular excitatory amino acids in the hippocampus of PTZ-kindled epileptic and PTZ-induced status epilepticus rats. Neurochem Res. 38:504–511.
  • Duan W, Zhang YP, Hou Z, Huang C, Zhu H, Zhang CQ, Yin Q. 2015. Novel insights into NeuN: from neuronal marker to splicing regulator. Mol Neurobiol. 53:1637–1647.
  • Fujikawa DG, Itabashi HH, Wu A, Shinmei SS. 2000. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia. 41:981–991.
  • Gao J, Wang WY, Mao YW, Gräff J, Guan JS, Pan L, Mak G, Kim D, Su SC, Tsai LH. 2010. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 466:1105–1109.
  • Hall AM, Brennan GP, Nguyen TM, Singh-Taylor A, Mun HS, Sargious MJ, Baram TZ. 2017. The role of Sirt1 in epileptogenesis. eNeuro. 4 (1)e0301-16.2017 1–11.
  • Hasselblatt M, Ehrenreich H, Sirén AL. 2006. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol. 18:132–138.
  • Houtkooper RH, Pirinen E, Auwerx J. 2012. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol. 13:225–238.
  • Isik AT, Celik T, Ulusoy G, Ongoru O, Elibol B, Doruk H, Bozoglu E, Kayir H, Mas MR, Akman, S. 2009. Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model. Age. 31:39–49.
  • Kakefuda K, Fujita Y, Oyagi A, Hyakkoku K, Kojima T, Umemura K, Tsuruma K, Shimazawa M, Ito M, Nozawa Y, Hara H. 2009. Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection. Biochem Biophys Res Commun. 387:784–788.
  • Kaptan Z, Akgün-Dar K, Kapucu A, Dedeakayoğulları H, Batu Ş, Üzüm G. 2015. Long term consequences on spatial learning-memory of low-calorie diet during adolescence in female rats; hippocampal and prefrontal cortex BDNF level, expression of NeuN and cell proliferation in dentate gyrus. Brain Res. 1618:194–204.
  • Kesner RP. 2013. A process analysis of the CA3 subregion of the hippocampus. Front Cell Neurosci. 7:78.
  • Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, Yoon JS. 2007. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psych. 62:423–428.
  • Koyama R, Ikegaya Y. 2005. To BDNF or not to BDNF: that is the epileptic hippocampus. Neuroscientist. 11:282–287.
  • Kwan P, Brodie MJ. 2000. Early identification of refractory epilepsy. N Engl J Med. 342:314–319.
  • Lavezzi AM, Corna MF, Matturri L. 2013. Neuronal nuclear antigen (NeuN): a useful marker of neuronal immaturity in sudden unexplained perinatal death. J Neurol Sci. 329:45–50.
  • Lipsky RH, Marini AM. 2007. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann NY Acad Sci. 1122:130–143.
  • Lüttjohann A, Fabene PF, Luijtelaar G. 2009. A revised Racine’s scale for PTZ-induced seizures in rats. Physiol Behav. 98:579–586.
  • Martin SJ, Grimwood PD, Morris RG. 2000. Synaptic plasticity and memory: an evaluation of the hypothesis. Ann Rev Neurosci. 23:649–671.
  • Mathern GW, Adelson PD, Cahan LD, Leite JP. 2002. Hippocampal neuron damage in human epilepsy: Meyer’s hypothesis revisited. Prog Brain Res. 135:237–251.
  • Meldrum BS. 2002. Concept of activity-induced cell death in epilepsy: historical and contemporary perspectives. Prog Brain Res. 135:3–11.
  • Merelli A, Czornyj L, Lazarowski A. 2015. Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases. Int J Neurosci 125:793–797.
  • Michan S, Li Y, Chou MMH, Parrella E, Ge H, Long JM, Allard JS, Lewis K, Miller M, Xu W, Mervis RF. 2010. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci. 30:9695–9707.
  • Min SW, Sohn PD, Cho SH, Swanson RA, Gan L. 2013. Sirtuins in neurodegenerative diseases: an update on potential mechanisms. Front Aging Neurosci. 5:53.
  • Murer MG, Yan Q, Raisman-Vozari R. 2001. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol. 63:71–124.
  • Nadam J, Navarro F, Sanchez P, Moulin C, Georges B, Laglaine A, Pequignot JM, Morales A, Ryvlin P, Bezin, L. 2007. Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol Dis. 25:412–426.
  • Noguchi CT, Wang L, Rogers HM, Teng R, Jia Y. 2008. Survival and proliferative roles of erythropoietin beyond the erythroid lineage. Exp Rev Mol Med. 10:e36.
  • Paudel YN, Lisgaras CP, Lim KS, Shaikh MF. 2018. Epilepsy and comorbidities: towards unraveling the common underlying mechanisms. NeurosciRN. 1:1–4.
  • Postnikova TY, Trofimova AM, Zaitsev AV, Magazaniket LG. 2017. Status epilepticus induced by pentylenetetrazole increases short-term synaptic facilitation in the hippocampus of juvenile rats. Dokl Biol Sci. 477:207–209.
  • Scharfman HE, Goodman JH, Sollas AL, Croll SD. 2002. Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neurol. 174:201–214.
  • Stables JP, Bertram EH, White HS. 2002. Models for epilepsy and epileptogenesis: report from the NIH workshop Bethesda, Maryland. Epilepsia. 43:1410–1420.
  • Uzum G, Diler AS, Bahçekapılı N, Ziylan YZ. 2006. Erythropoietin prevents the increase in blood–brain barrier permeability during pentylentetrazol induced seizures. Life Sci. 78:2571–2576.
  • Vasilev, DS, Tumanova NL, Kim KK, Lavrentyeva VV, Lukomskaya NY, Zhuravin IA, Igor A, Magazanik LG and Zaitsev AV. 2018. Transient morphological alterations in the hippocampus after pentylenetetrazole-induced seizures in rats. Neurochem Res. 43:1671–1682.
  • Walker MC. 2015. Hippocampal sclerosis: causes and prevention. Sem Neurol. 35:193–200.
  • Wang SJ, Zhao XH, Chen W, Bo N, Wang XJ, Chi ZF, Wu W. 2015. Sirtuin 1 activation enhances the PGC-1α/mitochondrial antioxidant system pathway in status epilepticus. Mol Med Rep. 11:521–526.
  • Wang Y, Liu X, Wang Y, Chen J, Han T, Su L, Zang K. 2017. Attenuation of pentylenetrazole-induced acute status epilepticus in rats by adenosine involves inhibition of the mammalian target of rapamycin pathway. Neuro Rep. 28:1016–1021.
  • Warburton A, Miyajima F, Shazadi K, Crossley J, Johnson MR, Marson AG, Baker GA, Quinn JP, Sills GJ. 2016. NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy. Epilep Behav. 54:117–127.
  • Wu H, Wang H, Zhang W, Wei X, Zhao J, Yan P, Liu C. 2015. rhEPO affects apoptosis in hippocampus of aging rats by upregulating SIRT1. Int J Clin Exp Pathol. 8:6870–6880.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.